Biotesserae Camunity
BioTesserae is a research-focused organization that pursues development of biologic cancer therapies for companion animals. The team comprises clinicians and scientists working on antibody- and nanobody-based approaches, translational immunotherapy research, and partnerships with academic and accelerator organizations to advance veterinary oncology therapeutics.
Industries
Nr. of Employees
small (1-50)
Biotesserae Camunity
Services
Research and development activities focused on antibody- and nanobody-based therapeutics intended for veterinary oncology applications.
Connection to accelerators, incubators and consultants to support translation and early commercialization of veterinary biologics.
Research and development activities focused on antibody- and nanobody-based therapeutics intended for veterinary oncology applications.
Connection to accelerators, incubators and consultants to support translation and early commercialization of veterinary biologics.
Expertise Areas
- Veterinary oncology research
- Biologic therapeutics (antibodies and nanobodies)
- Immunotherapy translational research
- Preclinical development for companion animals
Key Technologies
- Nanobody engineering
- Monoclonal antibody therapeutics
- Immunotherapy approaches
- Translational oncology methods
News & Updates
Journal article discussing the considerations of applying human biological immunotherapies in veterinary oncology.
Media coverage about research efforts to develop cancer treatments for dogs.
News article describing an NSF grant supporting development of antibody treatments for dogs with cancer.
Research article describing development of a selective nanobody against a specific protein modification.
Magazine article noting support for early commercialization efforts related to the organization’s work.
Feature article in Animal Connection highlighting the group and their work (winter issue).
Journal article discussing the considerations of applying human biological immunotherapies in veterinary oncology.
Media coverage about research efforts to develop cancer treatments for dogs.
News article describing an NSF grant supporting development of antibody treatments for dogs with cancer.
Research article describing development of a selective nanobody against a specific protein modification.
Magazine article noting support for early commercialization efforts related to the organization’s work.
Feature article in Animal Connection highlighting the group and their work (winter issue).